Development of Irreversible Inhibitors of MELK Kinase

Abstract

We have performed 3 rounds of in silico docking combined with in vitro MELK kinase activity assays. We have identified 5 independent scaffolds capable of MELK inhibition in the range of 100nm-1um. These compounds are capable to tightly bind MELK catalytic domain as measured by DCS, ruling out the protein aggregation and other non-specific inhibiotry modalities. These leads are now being developed into potent anti-MELK drugs.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2008
Accession Number
ADA492687

Entities

People

  • Alexey V. Terskikh

Organizations

  • Sanford Burnham Prebys Medical Discovery Institute

Tags

DTIC Thesaurus Topics

  • Amino Acids
  • Androgen Receptors
  • Biomedical Research
  • Breast Cancer
  • Heat Capacity
  • Inhibition
  • Inhibitors
  • Kinases
  • Macromolecules
  • Mammary Glands
  • Molecules
  • Neoplasms
  • Optical Properties
  • Prostate Cancer
  • Proteins
  • Recombinant Proteins
  • Small Molecules

Readers

  • Molecular and Cellular Biochemistry